Integer Holdings (ITGR) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$1.8B

Revenue (quarter)

$464.1M

Revenue growth (year over year)

−2.60%

Gross profit (trailing twelve months)

$473.5M

Gross margin

25.68%

Net income (trailing twelve months)

$128.4M

Net income (quarter)

$23.6M

Net income growth (year over year)

−36.22%

Net margin

6.97%

Return on equity

7.50%

EPS (trailing twelve months)

$3.71

Book value per share

$50.56

P/E (trailing twelve months)

33.52

Price to book

2.50

Debt to assets

49.80%

Payout ratio

—

Dividend yield

—

Company profile

Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.

• Is Integer Holdings (ITGR) profitable?

  Yes. Integer Holdings earned $128.4M in net income over the trailing twelve months, a net margin of 6.97%.

• How much revenue does Integer Holdings (ITGR) make?

  Integer Holdings generated $1.8B in revenue over the trailing twelve months, down 2.60% year over year.

• What is ITGR's P/E ratio?

  Integer Holdings trades at 33.5 times trailing twelve-month earnings, on an EPS of $3.71.

• How do I buy stock in Integer Holdings (ITGR)?

  ITGR trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.